Alembic Pharmaceuticals Ltd.

Contact Information

Legal Address
Alembic Road, ,
Vadodara; Gujarat; Map
Postal Code: 390003
Tel: 2280550/ 2280880/
Fax: 2282506
Email: apl.investors@alembic.co.in
Website: http://www.alembic-india.com

Full name: Alembic Pharmaceuticals Ltd.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
EMISid: 3267209
IN-CIN: U24230GJ2010PLC061123
Incorporation Date: 1907

Main Activities

Main Activities: Pharmaceutical and Medicine Manufacturing

Main Products

pharmaceutical products, pharmaceutical substances and Intermediates

Company Description

Alembic Pharmaceuticals Limited develops, manufactures and markets pharmaceutical products, pharmaceutical substances and Intermediates. The company is in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The company was established in 1907 and hast its office based in Vadodara.

More

Basic Information

Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()

EMIS Benchmark Score

Quote Chart

Quote Summary

Last Price 593.70
Volume 10,226
Turnover 6,084,470
Index    S&P CNX 500
Market Bombay Stock Exchange
Ticker 533573
Market Cap Market Cap 111,921,898
52 Week High 753.85
52 Week Low 526.90
P/E 16.03
EPS 37.03
Dividend Yield 2.5 (March 31, 2013)
Bookvalue
Enterprise Value 110,374,558
Quote updated on July 26, 2016
Note: data in INR Thousands.

Export-Import

2014: Imports INR 1,933,192.00 Thousands
Import connections ('000)
Total(30,524.97)
2014: Exports INR 7,501,748.00 Thousands
Export connections ('000)
Total(118,452.08)

Key Executives

Chairman & Managing Director
More

Ownership Details

Indian Promoters
74.13%
More

Key Stats

Select Items to chart them. 2016 Y
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets 21,891,100
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: Dion Global Solutions Limited, EMIS Company Database.

Financials

Competitors - India

INR | USD | EUR

Financial Documents/Annual Reports

Corporate Actions

Analysis/Research

EMIS DealWatch News

EMIS DealWatch Deals

DealMonitor Deal Intents

for 29.95 USD
Most recent financial data: 2016
Payment methods include:
USD 29.95
Most recent financial data: 2016
EMIS is able to provide you with immediate access to a full company report for Alembic Pharmaceuticals Ltd.. The table below indicates the information that your report will contain:
Payment methods include:
The full report for this company will be available to download immediately after purchase. The report will contain:
Company Tear Sheet
Contact Information
NAICS Industry Classification
Business description
Basic Information
Share Price information
Key Executives
Ownership Details
Subsidiaries and Affiliates
Key Financial Highlights
Financial Performance Charts
Latest M&A and ECM Deals
Top Competitors
Financial Statements
Annual Statements
Ratios
EMIS Credit Analytics
EMIS Benchmark Score

- or -

EMIS Company Profiles are part of a larger information service where that combines company, industry and country data and analysis for over 120 emerging markets on a unique information platform.

If you need broad and deep coverage of one or many countries, you may be interested in subscribing. Request a demonstration of our full service and one of our account managers will be in touch.

Register Your Interest